Exposure | Category | Adenocarcinoma | Squamous cell carcinoma | ||
---|---|---|---|---|---|
Crude RR | Adjusted RR1 | Crude RR | Adjusted RR2 | ||
BMI in WHO categories | ≤ 18.4 | - | - | 1.68 (0.62–4.56) | 1.54 (0.56–4.19) |
18.5–25.0 | Reference | Reference | Reference | Reference | |
25.0–29.9 | 2.53 (1.66–3.88) | 2.32 (1.51–3.57) | 0.65 (0.47–0.90) | 0.67 (0.49–0.93) | |
≥ 30 | 2.69 (1.50–4.85) | 3.29 (1.82–5.95) | 0.39 (0.19–0.77) | 0.47 (0.24–0.94) | |
≥ 25 | 2.57 (1.70–3.88) | 2.47 (1.63–3.74) | 0.60 (0.44–0.82) | 0.64 (0.47–0.87) | |
ESH/ESC hypertension criteria3 | Normal | Reference | Reference | Reference | Reference |
Grade 1 | 1.13 (0.74–1.72) | 0.90 (0.59–1.32) | 1.34 (0.96–1.87) | 1.61 (1.15–2.26) | |
Grade 2 | 1.47 (0.84–2.57) | 1.11 (0.63–1.96) | 1.42 (0.89–2.26) | 1.98 (1.23–3.17) | |
Grade 3 | 0.93 (0.33–2.62) | 0.66 (0.23–1.87) | 1.96 (1.10–3.59) | 2.95 (1.62–5.37) | |
Grade 1–3 | 1.19 (0.81–1.74) | 0.93 (0.63–1.37) | 1.41 (1.04–1.91) | 1.77 (1.30–2.42) | |
Ptrend | 0.39 | 0.72 | 0.01 | <0.0001 |